Search

everythinglearnresearchcommunity

for

Search:↓

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Recombinant collagen with nicotinamide boosts hair growth and health.

Traditional methods may not fully capture how the brain and breathing systems respond to carbon dioxide changes.

The workshop promoted better medicine use and health practices through global collaboration.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

LSCI-HR is reliable for monitoring blood flow in wound healing in mice.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

A systems biology approach helps improve mesenchymal stromal cell therapies by mapping interactions and identifying treatment targets.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Platelet-rich plasma may improve vitiligo treatment when used with phototherapy.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Stem cells are more dynamic and adaptable than previously believed.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

RoPod helps study plant root cell changes and autophagy with minimal stress.

The treatment was not recommended due to limited effectiveness and significant side effects.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Wharton's jelly stem cells show diverse traits and functions.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

The syringe method is better for preparing platelet-rich plasma.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

BOOST is a promising, easy-to-use treatment for diabetic foot ulcers that improves healing by reducing inflammation and promoting blood vessel growth.

A CCS patient with severe complications was successfully treated using combined therapies.

Platelet-rich plasma treatment is more effective than pelvic floor muscle training for improving quality of life in women with stress urinary incontinence.

Providing housing and case management reduces hospital visits for chronically ill homeless adults.

Tattoo machine-assisted drug delivery may improve hair growth in androgenetic alopecia.